Hemostatic Closure of Femoral Artery Access Site, Using the QuickClose Design 9 System

PHASE1/PHASE2WithdrawnINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

May 31, 2011

Conditions
CoagulationTherapeutic UsesPharmacologic Actions
Interventions
DEVICE

closure device

the invasive specialist must carefully manage the difficult balance of patient anticoagulation and coagulation for stopping the bleeding at the femoral artery puncture site. the QuickClose design 9 system is designed to benefit the patients and the medical staff by improving the process. the risks to patients associated with this study are considered reasonable in comparison to the anticipated benefits to the subjects, and the scientific knowledge that can be gained from the study.

Trial Locations (1)

Unknown

Heart Institute Sheba medical center, Tel Litwinsky

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Sheba Medical Center

OTHER_GOV

lead

CardioDex

INDUSTRY